SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-20-001390
Filing Date
2020-11-05
Accepted
2020-11-05 16:37:10
Documents
14
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620062_8k-adma.htm   iXBRL 8-K 20960
2 e620062_ex99-1.htm EX-99.1 92436
3 GRAPHIC image_001.jpg GRAPHIC 4117
  Complete submission text file 0001193805-20-001390.txt   305768

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adma-20201105.xsd EX-101.SCH 3201
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20201105_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20201105_pre.xml EX-101.PRE 22720
7 EXTRACTED XBRL INSTANCE DOCUMENT e620062_8k-adma_htm.xml XML 3494
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 201291080
SIC: 2836 Biological Products, (No Diagnostic Substances)